The Impact of Different Skin Suture Methods in Episiotomy Repair on Healing and Pain

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

132 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-01

Study Completion Date

2022-09-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Episiotomy is the intentional incision of the perineum during vaginal birth in order to accelerate the active phase of labor. This study aimed to compare various skin closure techniques in episiotomy repair.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Simple Continuous, Subcuticular and Interrupted Skin Suturing of Episiotomy and 2nd-degree Perineal Tears

NCT03611452

Episiotomy Wound

UNKNOWN NA

Different Techniques for Perineal Skin Closure During Mediolateral Episiotomy Repair

NCT03780530

Episiotomy

UNKNOWN PHASE3

Repair of Lateral And Mediolateral Episiotomy

NCT03486132

Episiotomy Wound

UNKNOWN NA

Continuous Versus Interrupted Sutures for Repair of Episiotomy or Second Degree Tears: a Randomised Controlled Trial

NCT00777270

Pain

COMPLETED NA

The Effect of Suturing Material on Scar Healing

NCT03968783

Wound Heal Cesarean Section Complications Cesarean Wound Disruption +1 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Labor; Prolonged, Second Stage Episiotomy Wound

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

M-Suture

Episiotomy repair is completed until the skin closure. Interrupted mattress suturing technique is applied to this arm.

Group Type ACTIVE_COMPARATOR

Mattress Suturing

Intervention Type PROCEDURE

Horizontal mattress suture in interrupted fashion

I-Suture

Episiotomy repair is completed until the skin closure. Interrupted primary suturing technique is applied to this arm.

Group Type ACTIVE_COMPARATOR

Primary Suturing

Intervention Type PROCEDURE

Horizontal primary suture in interrupted fashion

SC-Suture

Episiotomy repair is completed until the skin closure. Continuous subcutaneous suturing technique is applied to this arm.

Group Type ACTIVE_COMPARATOR

Continuous Subcutaneous Suturing

Intervention Type PROCEDURE

Subcutaneous suture in continuous fashion

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mattress Suturing

Horizontal mattress suture in interrupted fashion

Intervention Type PROCEDURE

Primary Suturing

Horizontal primary suture in interrupted fashion

Intervention Type PROCEDURE

Continuous Subcutaneous Suturing

Subcutaneous suture in continuous fashion

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primiparous
* Age between 18 to 45
* Given birth in our labor ward

Exclusion Criteria

* Multiparous
* having deep vaginal lacerations
* having abnormalities in fetus
* Rheumatologic diseases
* Postpartum bleeding
* Shoulder Dystocia
* Operative Delivery
* Using antithrombotic or anticoagulant medications

Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes